Health Encyclopedia

Sedapap-10

Sedapap-10: Uses, Dosage, and Side Effects Guide

Introduction to Sedapap-10

Sedapap-10 is a prescription medication used to treat tension headaches. It contains a combination of acetaminophen, a pain reliever, and butalbital, a sedative. Sedapap-10 works by decreasing pain and promoting relaxation to provide relief from tension headache symptoms. Common brand names for this medication include Bancap, Phrenilin, and Triaprin.

Chemical Composition

Each Sedapap-10 tablet contains:

The chemical formula for acetaminophen is C 8H 9NO 2, while butalbital has the formula C 11H 16N 2O 3.

Pharmacological Classification

Sedapap-10 is classified as both an analgesic (pain reliever) and a sedative. Acetaminophen acts on the central nervous system to decrease pain perception, while butalbital enhances the inhibitory effects of GABA to promote sedation and muscle relaxation.

Medical Uses

The primary FDA-approved use for Sedapap-10 is the treatment of tension headaches. Tension headaches cause mild to moderate pain, often described as a tight band around the head. Sedapap-10 provides relief by targeting both the pain and muscle tension associated with these headaches.

Dosage and Administration

The standard dosage for Sedapap-10 is 1-2 tablets every 4 hours as needed, not to exceed 6 tablets in 24 hours. Dosage may need to be adjusted for patients with renal impairment. The maximum recommended daily dose is 1000 mg of acetaminophen and 300 mg of butalbital for adults.

Side Effects

Common side effects of Sedapap-10 (occurring in 1-10% of patients) include:

Less common side effects (0.1-1% of patients) may include:

Rare but severe side effects require immediate medical attention.

Long-Term Usage Concerns

Long-term use of Sedapap-10 can lead to risks such as increased tolerance, dependency, and potential for withdrawal symptoms upon discontinuation. Patients should follow their prescribed dosing schedule and consult their doctor if they feel they need to take Sedapap-10 more frequently or at higher doses.

Drug Interactions

Sedapap-10 can have additive effects when combined with other sedative medications or alcohol, increasing drowsiness and impairing motor function. Patients should avoid alcohol and consult their doctor or pharmacist before taking any new medications with Sedapap-10.

Contraindications

Sedapap-10 is contraindicated in patients with known allergies to acetaminophen, butalbital, or any components of the formulation. It should be used cautiously in patients with a history of liver disease, renal dysfunction, or acute abdominal conditions. Sedapap-10 may be habit-forming and should not be used in patients with a history of drug abuse or dependency.

Special Populations

Sedapap-10 is in FDA Pregnancy Category C, meaning it should only be used during pregnancy if the potential benefit justifies the risk. It may also be present in breast milk and cause drowsiness in nursing infants. The safety and effectiveness of Sedapap-10 has not been established in pediatric populations. Geriatric patients may be more sensitive to the sedative effects.

Comparative Effectiveness

Clinical studies have shown Sedapap-10 to be effective at relieving tension headache pain and associated symptoms compared to placebo. Its effectiveness is comparable to other combination analgesics like Fioricet, which contains acetaminophen, butalbital, and caffeine.

Regulatory Aspects

Butalbital is a Schedule III controlled substance, meaning it has medical uses but also potential for abuse and dependence. Sedapap-10 is only available by prescription. It was first approved by the FDA in 1979, with generic versions approved more recently.

Alternatives to Sedapap-10

Alternatives for tension headache treatment include other analgesic-sedative combinations like Fioricet (with caffeine), non-sedative pain relievers like NSAIDs and acetaminophen alone, and non-pharmacological therapies like relaxation techniques, biofeedback, and lifestyle changes to reduce stress.

Clinical Studies and Research

A 2015 rat study found that acetaminophen may alter collagen cross-linking in skeletal muscles like the gastrocnemius. Another study showed Sedapap-10 treatment significantly decreased headache severity compared to placebo.

Patient and User Reviews

On user review sites, Sedapap-10 has an average rating of 8.5/10 for treating tension headaches. Many patients report significant relief of pain and tension, with drowsiness being the most commonly noted side effect. Some users express concern about its potential for dependency with regular use.

Manufacturing and Distribution

Sedapap-10 is manufactured by several pharmaceutical companies including Midlothian Laboratories and Mikart, Inc. Brand name versions like Phrenilin are distributed by Valeant Pharmaceuticals. Generic versions are available from multiple manufacturers.

Historical Context

Combination analgesics containing butalbital and acetaminophen have been used to treat tension headaches since the 1960s. Sedapap-10 first became available in the United States in 1982. Its use has declined somewhat with the development of newer migraine-specific medications.

FAQs and Misconceptions

Is Sedapap-10 a narcotic? Sedapap-10 is not a narcotic, but butalbital is a controlled substance with risk for dependence and withdrawal.

Can I take Sedapap-10 every day? Sedapap-10 is intended for occasional, as-needed use. Taking it daily increases the risk of tolerance and dependency. Consult your doctor if you get tension headaches frequently.

Economic Aspects

Brand name Sedapap-10 can cost over $200 for 100 tablets. Generic versions are significantly cheaper, around $40-$75 for 100 tablets. Most insurance plans cover Sedapap-10 with a prescription, but quantity limits may apply.

As a controlled substance, butalbital prescribing is monitored to help prevent abuse and diversion. Doctors must weigh the risks and benefits when prescribing Sedapap-10, especially for patients with a history of substance abuse. Pharmacies must follow strict record-keeping and inventory requirements.

Sedapap-10